-
Loading metrics
Open Access
Peer-reviewed
Research Article
NCYM, a Cis-Antisense Gene of MYCN, Encodes a De Novo Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas
-
Yusuke Suenaga,
Affiliation Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
S. M. Rafiqul Islam,
Affiliation Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
Jennifer Alagu,
Affiliation Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
Yoshiki Kaneko,
Affiliation Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
Mamoru Kato,
Affiliation Division of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan
⨯ -
Yukichi Tanaka,
Affiliation Department of Diagnostic Pathology, Research Institute, Kanagawa Children's Medical Center, 2-138-4 Mutsukawa, Minami-ku, Yokohama, Japan
⨯ -
Hidetada Kawana,
Affiliation Division of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
Shamim Hossain,
Current address: Department of Integrative Physiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Japan.
Affiliation Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
Daisuke Matsumoto,
Affiliation Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
Mami Yamamoto,
Affiliation Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
Wataru Shoji,
Affiliations Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan, Department of Pediatric Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan
⨯ -
Makiko Itami,
Affiliation Division of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
Tatsuhiro Shibata,
Affiliation Division of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan
⨯ -
Yohko Nakamura,
Affiliation Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
Miki Ohira,
Affiliation Laboratory of Cancer Genomics, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
Seiki Haraguchi,
Current address: Animal Breeding and Reproduction Division, NARO Institute of Livestock and Grassland Science, 2 Ikenodai, Tsukuba, Japan.
Affiliation Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ -
Atsushi Takatori,
Affiliation Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ - [ ... ],
-
Akira Nakagawara
* E-mail: akiranak@chiba-cc.jp
Affiliation Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Japan
⨯ - [ view all ]
- [ view less ]
NCYM, a Cis-Antisense Gene of MYCN, Encodes a De Novo Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas
- Yusuke Suenaga,
- S. M. Rafiqul Islam,
- Jennifer Alagu,
- Yoshiki Kaneko,
- Mamoru Kato,
- Yukichi Tanaka,
- Hidetada Kawana,
- Shamim Hossain,
- Daisuke Matsumoto,
- Mami Yamamoto
- Published: January 2, 2014
- https://doi.org/10.1371/journal.pgen.1003996